T2	Condition 314 328	BH4 deficiency
E2	Condition:T2 Name:T16
T3	Drug 354 359	KUVAN
E3	Drug:T3 Name:T17 Dose:E5
T5	Eq-Comparison 371 386	at least 1 dose
E5	Eq-Comparison:T5 Operator:T18 Value:T19 Unit:T1
T6	Condition 396 399	HPA
E6	Condition:T6 Name:T20
T7	Condition 410 424	BH4 deficiency
E7	Condition:T7 Name:T21
T8	Temporal-Connection 425 431	during
E8	Temporal-Connection:T8 Arg:E7 Arg2:E9
A1	Temporal-Connection-Type-Value E8 during
T9	Study 446 457	observation
E9	Study:T9 
T10	Observation 473 490	Phe concentration
E10	Observation:T10 Name:T22 Eq-Comparison:E11
T11	Eq-Comparison 491 503	≥ 450 µmol/L
E11	Eq-Comparison:T11 Operator:T24 Value:T25 Unit:T26 Per:T27
T12	Condition 555 570	Phenylketonuria
E12	Condition:T12 Name:T28
T13	Condition 572 575	PKU
E13	Condition:T13 Name:T29
T14	Condition 590 599	condition
E14	Condition:T14 
T15	Negation 707 710	not
E15	Negation:T15 
T16	Condition-Name 314 328	BH4 deficiency
T17	Drug-Name 354 359	KUVAN
T18	Eq-Operator 371 379	at least
A2	Eq-Operator-Value T18 GTEQ
T19	Eq-Value 380 381	1
T20	Condition-Name 396 399	HPA
T21	Condition-Name 410 424	BH4 deficiency
T22	Observation-Name 473 490	Phe concentration
A3	Observation-Type-Value T22 lab
T24	Eq-Operator 491 492	≥
A5	Eq-Operator-Value T24 GTEQ
T25	Eq-Value 493 496	450
T26	Eq-Unit 497 501	µmol
T27	Eq-Unit 502 503	L
T28	Condition-Name 555 570	Phenylketonuria
T29	Condition-Name 572 575	PKU
T1	Eq-Unit 382 386	dose
R1	Treatment-For Arg1:E3 Arg2:E6	
R2	Caused-By Arg1:E6 Arg2:E7	
R3	Abbrev-Of Arg1:E13 Arg2:E12	
